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There were some errors in [Table 3](#T3){ref-type="table"}, [Supplementary data 3](#sup1){ref-type="supplementary-material"} and [Supplementary data 5](#sup2){ref-type="supplementary-material"} in the original article. These have now been corrected in the online version.

###### 

Number of prevalent users of disease modifying medication in Norwegian patients with inflammatory bowel disease two years before and after first dispense of low dose naltrexone (LDN). Three groups based on number of LDN dispenses: LDN x 1 (N = 189) collected LDN once, LDN x 2-3 (N = 137) two or three times and LDN x 4+ (N = 256) four or more times. Other systemic immunosuppressants include azathioprine, methotrexate, mercaptopurine, cyclosporine, and tacrolimus.

                                                      Users before LDN   Users after LDN   \% points change in number of users   *p*                              
  ------------------------------------- ------------- ------------------ ----------------- ------------------------------------- ------ ------- ----------------- -------
  All outcome drugs                     *LDN x1*      139                73.5              141                                   74.6   1.1     (-6.8 to 9.0)     0.793
                                        *LDN x 2-3*   109                79.6              98                                    71.5   -8.0    (-15.6 to -0.4)   0.043
                                        *LDN x 4+*    216                84.4              191                                   74.6   -9.8    (-15.3 to -4.2)   0.001
  Systemic immunosuppressants           *LDN x1*      93                 49.2              95                                    50.3   1.1     (-6.6 to 8.7)     0.786
                                        *LDN x 2-3*   73                 53.3              69                                    50.4   -2.9    (-11.0 to 5.2)    0.481
                                        *LDN x 4+*    137                53.5              121                                   47.3   -6.3    (-12.4 to -0.1)   0.050
  Systemic corticosteroids              *LDN x1*      71                 37.6              71                                    37.6   0.0     (-8.3 to 8.3)     1.000
                                        *LDN x 2-3*   60                 43.8              54                                    39.4   -4.4    (-12.9 to 4.2)    0.319
                                        *LDN x 4+*    107                41.8              92                                    35.9   -5.9    (-12.4 to 0.6)    0.080
  TNF-α inhibitors                      *LDN x1*      32                 16.9              30                                    15.9   -1.1    (-6.5 to 4.4)     0.706
                                        *LDN x 2-3*   14                 10.2              15                                    10.9   0.7     (-4.8 to 6.3)     0.797
                                        *LDN x 4+*    27                 10.5              25                                    9.8    -0.8    (-4.3 to 2.0)     0.468
  Other systemic immunosuppressants     *LDN x1*      39                 20.6              33                                    17.5   -3.2    (-8.4 to 2.1)     0.241
                                        *LDN x 2-3*   23                 16.8              28                                    20.4   3.6     (-3.2 to 10.5)    0.299
                                        *LDN x 4+*    45                 17.6              32                                    12.5   -5.1    (-8.8 to -1.3)    0.010
  Intestinal anti-inflammatory agents   *LDN x1*      109                57.7              102                                   54.0   -3.7    (-11.8 to 4.4)    0.371
                                        *LDN x 2-3*   82                 59.9              72                                    52.6   -7.3    (-15.8 to 1.2)    0.098
                                        *LDN x 4+*    168                65.4              140                                   54.5   -10.9   (-17.0 to -4.7)   0.001
  Intestinal corticosteroids            *LDN x1*      42                 22.2              46                                    24.3   2.1     (-4.4 to 8.7)     0.528
                                        *LDN x 2-3*   40                 29.2              36                                    26.3   -2.9    (-11.7 to 5.9)    0.518
                                        *LDN x 4+*    53                 20.7              36                                    14.1   -6.6    (-11.7 to -1.6)   0.012
  Aminosalicylates                      *LDN x1*      89                 47.1              78                                    41.3   -5.8    (-12.7 to 1.1)    0.103
                                        *LDN x 2-3*   58                 42.3              50                                    36.5   -5.8    (-11.8 to 0.2)    0.061
                                        *LDN x 4+*    139                54.3              116                                   45.3   -9.0    (-14.3 to -3.6)   0.001

The method used (\*Altman) is not available in standard statistics packages, and had to be performed in Excel. When calculating p-values from Z-scores, the Excel function =NORM.S.DIST was mistakenly used. This gives approximately correct *p*-values for high Z-scores (statistical significant results), but the maximum max *p*-value output for this function is 0,4.

There are no results where the statistical significance status is changed. The differences in *p*-values is mainly affecting the most non-significant values making *p*-values larger. The results, conclusions and scientific understanding of the study remain unchanged.
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